Subsequent experiments revealed that the silencing of FASN diminishes HCC cell growth and increases apoptosis in vitro, and ablation of FASN completely suppresses AKT and AKT/c-Met driven HCC formation in mice [15,20,21]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.